Low folate levels are associated with reduced risk of colorectal cancer in a population with low folate status

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 10, 2014, Pages 2136-2144

  Gylling, Björn ^a   Van Guelpen, Bethany ^a   Schneede, Jörn ^a   Hultdin, Johan ^a   Ueland, Per Magne ^b   Hallmans, Göran ^a   Johansson, Ingegerd ^a   Palmqvist, Richard ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; VITAMIN BLOOD LEVEL; BLOOD; COLORECTAL NEOPLASMS; LIQUID CHROMATOGRAPHY; MIDDLE AGED; RISK; RISK FACTOR; TANDEM MASS SPECTROMETRY;

ADULT; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; COLORECTAL NEOPLASMS; FEMALE; FOLIC ACID; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; TANDEM MASS SPECTROMETRY;

EID: 84907486202     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-1352     Document Type: Article

References (47)

1. Folic acid for the prevention of neural tube defects. American Academy of Pediatrics. Committee on Genetics. Pediatrics 1999;104:325-7.
2. EFSA. Folic acid: an update on scientific development. Parma, Italy: European Food and Safety Authority; 2009. 216 p.
3. Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals. Lancet 2013;381:1029-36.
4. Lee JE, Willett WC, Fuchs CS, Smith-Warner SA, Wu K, Ma J, et al. Folate intake and risk of colorectal cancer and adenoma: modification by time. Am J Clin Nutr 2011;93:817-25.
5. Stevens VL, McCullough ML, Sun J, Jacobs EJ, Campbell PT, Gapstur SM. High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer. Gastroenterology 2011;141:98-105, e1.
6. Kennedy DA, Stern SJ, Moretti M, Matok I, Sarkar M, Nickel C, et al. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol 2011;35:2-10.
7. Glynn SA, Albanes D, Pietinen P, Brown CC, Rautalahti M, Tangrea JA, et al. Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev 1996;5: 487-94.
8. Kato I, Dnistrian AM, Schwartz M, Toniolo P, Koenig K, Shore RE, et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer 1999;79:1917-22.
9. Van Guelpen B, Hultdin J, Johansson I, Hallmans G, Stenling R, Riboli E, et al. Low folate levels may protect against colorectal cancer. Gut 2006;55:1461-6.
10. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Plasma folate and risk of colorectal cancer in a nested case-control study: the Japan Public Health Center-based prospective study. Cancer Causes Control 2008;19:67-74.
11. Le Marchand L, White KK, Nomura AM, Wilkens LR, Selhub JS, Tiirikainen M, et al. Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2009;18:2195-201.
12. Eussen SJ, Vollset SE, Igland J, Meyer K, Fredriksen A, Ueland PM, et al. Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev 2010;19:1328-40.
13. Weinstein SJ, Albanes D, Selhub J, Graubard B, Lim U, Taylor PR, et al. One-carbon metabolism biomarkers and risk of colon and rectal cancers. Cancer Epidemiol Biomarkers Prev 2008;17:3233-40.
14. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997;57: 1098-102.
15. Shrubsole MJ, Yang G, Gao YT,Chow WH, Shu XO, Cai Q, et al. Dietary B vitamin and methionine intakes and plasma folate are not associated with colorectal cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 2009;18:1003-6.
16. Lee JE, Wei EK, Fuchs CS, Hunter DJ, Lee IM, Selhub J, et al. Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes Control 2012;23:537-45.
17. Takata Y, Shrubsole MJ, Li H, Cai Q, Gao J, Wagner C, et al. Plasma folate concentrations and colorectal cancer risk: a case-control study nested within the Shanghai Men's Health Study. Int J Cancer 2014 Apr 2. [Epub ahead of print]
18. Mason JB. Unraveling the complex relationship between folate and cancer risk. Biofactors 2011;37:253-60.
19. Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 2007;51:267-92.
20. Van Guelpen B, Hultdin J, Johansson I, Witthoft C, Weinehall L, Eliasson M, et al. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function. J Intern Med 2009;266:182-95.
21. Norberg M, Blomstedt Y, Lonnberg G, Nystrom L, Stenlund H, Wall S, et al. Community participation and sustainability-evidence over 25 years in the Vasterbotten Intervention Programme. Glob Health Action 2012;5:1-9.
22. Weinehall L, Hallgren CG, Westman G, Janlert U, Wall S. Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care. Scand J Prim Health Care 1998; 16:171-6.
23. Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, et al. Nordic biological specimen banks as basis for studies of cancer causes and control-more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol 2007;46:286-307.
24. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, et al., editors. Cancer Incidence in Five Continents, Vol. X [electronic version]. Lyon: IARC.; 2013 [cited 2014 Apr 11]. Available from: http://ci5.iarc.fr.
25. Jansen EH, Beekhof PK, Cremers JW, Schenk E. Long-term (in) stability of folate and vitamin B12 in human serum. Clin Chem Lab Med 2012;50:1761-3.
26. Hustad S, Eussen S, Midttun O, Ulvik A, van de Kant PM, Morkrid L, et al. Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem 2012;58: 402-10.
27. BEVITAL [Internet]. Bergen, Norway: BEVITAL; c2003-2004 [updated 2014 Mar 21; cited 2014 Mar 23]. Available from: http://www.bevital. no.
28. Windelberg A, Arseth O, Kvalheim G, UelandPM. Automated assay for the determination of methylmalonic acid, total homocysteine, and related amino acids in human serum or plasma by means of methylchloroformate derivatization and gas chromatography-mass spectrometry. Clin Chem 2005;51:2103-9.
29. Midttun O, Kvalheim G, Ueland PM. High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using HPLC-MS/MS. Anal Bioanal Chem 2013;405: 2009-17.
30. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 2009;125:171-80.
31. Dahlin AM, Van Guelpen B, Hultdin J, Johansson I, Hallmans G, Palmqvist R. Plasma vitamin B12 concentrations and the risk of colorectal cancer: a nested case-referent study. Int J Cancer 2008; 122:2057-61.
32. Hirsch S, Sanchez H, Albala C, de la Maza MP, Barrera G, Leiva L, et al. Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroenterol Hepatol 2009;21:436-9.
33. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007;16:1325-9.
34. Keum N, Giovannucci EL. Folic acid fortification and colorectal cancer risk. Am J Prev Med 2014;46:S65-72.
35. Zschabitz S, Cheng TY, Neuhouser ML, Zheng Y, Ray RM, Miller JW, et al. B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort. Am J Clin Nutr 2013;97:332-43.
36. Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, Schernhammer ES, et al. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS ONE 2008;3:e3698.
37. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005;129:837-45.
38. Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 2012;61:847-54.
39. Yamauchi M, Lochhead P, Morikawa T, Huttenhower C, Chan AT, Giovannucci E, et al. Colorectal cancer: a tale of two sides or a continuum? Gut 2012;61:794-7.
40. Sheng X, Zhang Y, Zhao E, Lu S, Zheng X, Ge H, et al. MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies. Mol Biol Rep 2012;39:9669-79.
41. Giovannucci E. Nutrient biomarkers are not always simple markers of nutrient intake. Am J Clin Nutr 2013;97:657-9.
42. Bates CJ, Fuller NJ. The effect of riboflavin deficiency on methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.20) and folate metabolism in the rat. Br J Nutr 1986;55:455-64.
43. Eussen SJ, Vollset SE, Hustad S, Midttun O, Meyer K, Fredriksen A, et al. Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2010;19:2549-61.
44. Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, Pischon T, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ 2010;340: b5500.
45. Drogan D, Klipstein-Grobusch K, Wans S, Luley C, Boeing H, Dierkes J. Plasma folate as marker of folate status in epidemiological studies: the European Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Br J Nutr 2004;92:489-96.
46. Eussen SJ, Nilsen RM, Midttun O, Hustad S, Meyer K, et al. Northsouth gradients in plasma concentrations of B-vitamins and other components of one-carbon metabolism in Western Europe: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Br J Nutr 2013;110:363-74.
47. Kalmbach RD, Choumenkovitch SF, Troen AM, D'Agostino R, Jacques PF, Selhub J. Circulating folic acid in plasma: relation to folic acid fortification. Am J Clin Nutr 2008;88:763-8.